DSM-Firmenich, CH1216478797

DSM-Firmenich stock pre-market: EUR 99.77, prior close EUR 100.25

Published on 10/08/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock was EUR 99.77 pre-market at Lang & Schwarz at 8:11 a.m. CEST on October 8, 2026, down 0.48 percent versus the prior close.

Architektur-Render eines gläsernen Forschungsgebäudes nahe Kaiseraugst
dsm-firmenich AG (ISIN CH1216478797) unterhält einen Forschungsstandort nahe Kaiseraugst, hier als modernes Architektur-Render gezeigt, Illustration mit AI erstellt.

At 8:11 a.m. CEST on October 8, 2026, DSM-Firmenich stock was EUR 99.77 in pre-market trading at Lang & Schwarz. The price was down 0.48 percent versus the prior close at Lang & Schwarz of EUR 100.25 on October 7, 2026.

Pre-market trading

The Lang & Schwarz bid was EUR 99.38 and the ask was EUR 100.15. The quote reflects trading before the Xetra session, which is scheduled to begin at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of DSM-Firmenich stock.

Previous trading session

DSM-Firmenich is listed on Euronext Amsterdam under the ticker DSFIR and is also listed on the SIX Swiss Exchange. The company’s October 7 reference price for the Lang & Schwarz quote was EUR 100.25, providing the basis for the reported pre-market percentage change.

Share repurchase completed

On October 1, DSM-Firmenich announced that it had completed a EUR 540 million share repurchase program, according to the Globenewswire release. The program covered EUR 40 million for commitments under the group’s share-based compensation plans and EUR 500 million for reducing issued capital. Between September 28 and September 30, the company repurchased 193,100 shares at an average price of EUR 98.62, for a total of EUR 19.0 million. Overall, 7,169,147 shares were repurchased at an average price of EUR 75.32. DSM-Firmenich said 6,488,446 shares are intended for cancellation by the end of the first quarter of 2027, reducing issued shares by approximately 2.6 percent from 253,626,947 to 247,138,501.

More news and analysis on DSM-Firmenich stock

Disclaimer...

en | CH1216478797 | DSM-FIRMENICH | boerse | 70262204 | bgmi